SilverHawk

About the SilverHawk®

The SilverHawk Plaque Excision System removes plaque that blocks arteries and interrupts blood flow, in many cases treating multiple vessels and lesions with a single device.



The SilverHawk device is capable of removing significant amounts of plaque without overstretching the artery, which can cause barotrauma. Hundreds of milligrams of plaque are routinely removed from the arteries treated with the SilverHawk. By removing plaque, the SilverHawk creates an open channel for adequate blood flow without stretching the vessel.

Learn more about SilverHawk Plaque Excision:

---

SilverHawk – U.S.

In the U.S., the SilverHawk® System is FDA-cleared to treat de novo and restenotic lesions in the peripheral arteries, treating a wide range of anatomy reaching from the common femoral to the dorsalis pedis. It is most commonly used to treat the femoral-popliteal and tibial-peroneal arteries in the legs. A number of multi-center and single center studies have demonstrated positive safety and efficacy rates in a range of patients from those with mild leg pain to those with critical limb ischemia.